Insider tradingForm 4
Stoke Therapeutics, Inc. (STOK) Insider Trading
6 open-market trades reported since Aug 18, 2026: 0 purchases worth $0 and 6 sales worth $861K.
By insider
| Insider | Role | Buys | Bought | Sells | Sold |
|---|---|---|---|---|---|
| Barry Ticho | CHIEF MEDICAL OFFICER | 0 | $0 | 3 | $350K |
| Jonathan Allan | General Counsel | 0 | $0 | 2 | $108K |
| Edward M. Md Kaye | Director | 0 | $0 | 1 | $403K |
All trades
| Filed | Insider | Type | Value | 3 mo. after |
|---|---|---|---|---|
| Oct 2 | Barry TichoCHIEF MEDICAL OFFICER | ▼ SELL10b5-1 | $27K | |
| Oct 2 | Jonathan AllanGeneral Counsel | ▼ SELL10b5-1 | $17K | |
| Sep 3 | Barry TichoCHIEF MEDICAL OFFICER | ▼ SELL10b5-1 | $170K | |
| Aug 18 | Edward M. Md KayeDirector | ▼ SELL | $403K | |
| Aug 18 | Barry TichoCHIEF MEDICAL OFFICER | ▼ SELL | $153K | |
| Aug 18 | Jonathan AllanGeneral Counsel | ▼ SELL | $92K |
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings